Other disclosed activity · AMPH
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Gaugh David RussellDirector |  AMPHAmphastar Pharmaceuticals, Inc.Grant or award | A | — 8,143 sh | Jun 3, 2026 traded Jun 1, 2026 |
Director · Amphastar Pharmaceuticals, Inc. · Amphastar Pharmaceuticals, Inc. — Stock Option (right to buy)
Grant or award — administrative, little informational value
No reported dollar value · new position
Disclosed 2 business days after execution (deadline: 2)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Gaugh David RussellDirector | AMPHAmphastar Pharmaceuticals, Inc. Grant or award | A | — 8,143 sh | Jun 3, 2026 traded Jun 1, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Gaugh David Russell filed this Form 4 reporting a grant or award of AMPH on Jun 1, 2026. It became public on Jun 3, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.